In the current environment of risk and health ad safety, I completely agree.
If this product continues to lead the pack, and countries continue to legislate around risk and the need to specifically inform women - this will take off.
ARR will just keep flowing in.
IMO year 3 from the time SAS started will be the good year.
We will have year 1 products in the final year and looking to roll over
We will have the 200% growth accounts in the second year of service
We will have new accounts on stream riding a wave of company and product popularity
Personally can't wait! I see $2.00 per share +
VHT Price at posting:
51.5¢ Sentiment: Buy Disclosure: Held